Cancer Biomarkers: Too Many Tests, Too Few Cures
Blood tests and imaging studies that find early signs of cancer–often looking for cellular changes called biomarkers–are usually reported in banner headlines, but in many cases these “markers” fail to deliver the promised early detection that could lead to a cure. Cancer – Health – Conditions and Diseases – Biomarker – Organizations
Read more on ABC News
Cancer seminar is on Tuesday
Community members can learn, from the comfort of their homes or offices, about the importance of caring for the spirit when facing cancer at noon on Tuesday.
Read more on Williston Herald
Poor struggling with cancer
LONDON – THE growing burden of cancer in developing countries could be reduced without expensive drugs and equipment, scientists said on Monday, but it requires a global effort similar to the fight against HIV/AIDS. In a study in the Lancet, scientists from the United States, who have formed a Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries(GTF.CCC), said …
Read more on Straits Times
Cancer Research Technology grants Valirx global rights to develop VAL 201 for cancer treatment
Cancer Research Technology has signed a deal to provide biotech company ValiRx plc with the global rights to develop a promising compound to treat hormone-resistant prostate cancer.The compound, now called VAL 201, has been shown in pre-clinical tests in mice to stop growth of tumours which have been unresponsive to hormone treatments. VAL 201 blocks genes which can cause prostate cancer to …
Read more on News-Medical-Net

![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=77867697-7de6-4789-ade8-bb3cb5f767e5)

